Skip to main content
RevivaMed Solutions

About RevivaMed Solutions

Expanding global access to innovative solutions

RevivaMed Solutions distributes amniotic allografts and advanced wound-care products, delivering innovative regenerative solutions, unmatched service, and exceptional value to support better outcomes for patients and providers.

Expanding global access to innovative solutions: medical distribution, procurement solutions, nationwide and international outreach, and strategic partnerships.

What we do

Four capabilities, one purpose: making advanced wound-care products reachable for the teams that need them.

Medical Distribution

Amniotic allografts and advanced wound-care products sourced from established manufacturers.

Procurement Solutions

Product selection, sizing and ordering support built around how your team actually works.

Nationwide & International Outreach

Expanding global access to innovative solutions for providers and partners.

Strategic Partnerships

Working with manufacturers, distributors and healthcare systems to widen availability.

How we work

We are a distributor, not a manufacturer — which means our job is to make the right products available, documented and supported.

Provider focused

Every conversation starts with the wounds you actually treat — then we match products, sizes and quantities to that case mix.

Clinically driven

Product selection is grounded in published evidence and the manufacturer's own clinical and regulatory documentation.

Patient outcomes

Better access to advanced therapy should mean fewer patients waiting on a wound that will not close.

The products we distribute

Our manufacturer partner

The Membrane Wrap family of amniotic membrane allografts, the Microlyte antimicrobial matrix platform and APIS. The manufacturer's public materials describe research and development, clinical evidence, clinical trials, and quality infrastructure including FDA registration, tissue-bank registrations, Canada registration and AATB accreditation, alongside a reimbursement and services function for providers and distributors.

FastSkin

The FastSkin Patch — autologous whole blood clot technology prepared at point of care, FDA 510(k) cleared (BK251174, 11/07/2025) as a Class II medical device for the management of exuding cutaneous wounds under healthcare-professional supervision.

Partner with RevivaMed Solutions

Whether you are a clinic, a distribution partner or a healthcare system, start with a short note about what you need.